These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5223143)

  • 1. Oral diabetes drug controls blood fats, as well as sugar, in diabetics with and without heart disease.
    Ind Med Surg; 1966 Sep; 35(9):781. PubMed ID: 5223143
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting the heart while controlling blood sugar. New guidelines help define and refine the use of two diabetes drugs that could be a boon for people who also have heart disease.
    Harv Heart Lett; 2004 Mar; 14(7):1. PubMed ID: 15044139
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

  • 4. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipids and glucose tolerance in diabetes during therapy with a thyromimetic agent.
    Danowski TS; Limaye NR; Cohn RE; Grimes BJ; Narduzzi JV; Moses C
    Clin Pharmacol Ther; 1966; 7(4):482-9. PubMed ID: 5939971
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on the effect of Amotril].
    Fujita Y; Gotoh T; Teranishi Y; Katake T; Hagihara K
    Naika Hokan; 1968 Mar; 15(3):61-6. PubMed ID: 5691519
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower cholesterol to lower heart risk.
    Clark WL
    Diabetes Self Manag; 2004; 21(3):19, 21-2, 25. PubMed ID: 15206362
    [No Abstract]   [Full Text] [Related]  

  • 8. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes, heart, and glitazones].
    Philippe J
    Rev Med Suisse Romande; 2004 Mar; 124(3):133-5. PubMed ID: 15095655
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes mellitus and pharmacological therapy.
    Bernene J; Zgonis T; Jolly GP
    Clin Podiatr Med Surg; 2003 Oct; 20(4):635-53. PubMed ID: 14636030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral medication of diabetics].
    Aubertin J
    J Med Bord; 1965 Apr; 142(4):699-701. PubMed ID: 5829865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Better blood sugar control in diabetics. Insulin glargin--a long-acting insulin analogue].
    Schubert-Zsilavecz M; Wurglics M
    Pharm Unserer Zeit; 2001; 30(2):125-30. PubMed ID: 11279982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral anti-diabetics].
    Brégetzer J
    Rev Infirm; 1984 Dec; 34(19):33-40. PubMed ID: 6570074
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral drug therapy of diabetes mellitus from the standpoint of blood insulin values].
    Murakami M; Takeda R; Miyabo S; Morimoto S; Fujimura A
    Saishin Igaku; 1967 Oct; 22(10):2311-9. PubMed ID: 5588196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 18. Getting to the heart of diabetes. Move over, blood sugar. In the fight against diabetes, it's time to focus on managing cholesterol problems and blood pressure, too.
    Harv Heart Lett; 2004 Sep; 15(1):1-2. PubMed ID: 15381493
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.